Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/Gastroesophageal Adenocarcinoma Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Catenacci, Daniel VT
  • Kang, Yoon-Koo
  • Uronis, Hope E
  • Lee, Keun-Wook
  • Ng, Matthew CH
  • Enzinger, Peter C
  • Park, Se Hoon
  • Gold, Philip J
  • Lacy, Jill
  • Hochster, Howard S
  • Cheul, Sang
  • Kim, Yeul Hong
  • Marrone, Kristen A
  • Kelly, Ronan J
  • Juergens, Rosalyn
  • Kim, Jong Gwang
  • Alcindor, Thierry
  • Sym, Sun Jin
  • Song, Eun-Kee
  • Chee, Cheng Ean
  • Chao, Yee
  • Kim, Sunnie
  • Oh, Do-Youn
  • Yen, Jennifer
  • Odegaard, Justin I
  • Lagow, Errin
  • Li, Daner
  • Sun, Jichao
  • Kaminker, Patrick
  • Moore, Paul A
  • Rosales, Minori Koshiji
  • Park, Haeseong

publication date

  • April 2023